A similar outcome was observed in a human study that was single-blinded; ten patients with obesity and T2DM received an intrarectal infusion of taurocholate, and GLP-1, insulin and PYY were increased in a dose-dependent manner [112]. The gene discussed is GCG; the disease is Obesity.